Assessing risk of myocarditis following SARS-CoV-2 vaccination

What The Study Did: The risks of myocarditis and pericarditis after SARS-CoV-2 mRNA vaccinations were assessed by vaccine, dose number, sex and age among 23.1 million residents of Denmark, Finland, Norway and Sweden.

Authors: Rickard Ljung, M.D., Ph.D., M.P.H., of the Swedish Medical Products Agency in Uppsala, Sweden, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamacardio.2022.0583)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #